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Abstract Rats bearing the Zajdela hepatoma tumor and T3-
treated hypothyroid rats were used to study the role of protein
degradation in the process of mitochondrial biogenesis. It was
shown that the activity, protein and mRNA levels of the ATP-
dependent Lon protease increased in rapidly growing Zajdela
hepatoma cells. The increase in the rate of mitochondrial
biogenesis by thyroid hormone was similarly accompanied by
enhanced expression of the Lon protease. The results imply that
mitochondrial biogenesis in mammalian cells is, at least partially,
regulated by the matrix Lon protease.
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1. Introduction
A number of physiological conditions alter the expression
of the mitochondrial genome in mammalian cells [1^5]. How-
ever, these alterations are not always coordinated with
changes in the levels of extramitochondrially synthesized sub-
units, suggesting that expression of nuclear and mitochondrial
genes is not necessarily tightly coordinated. In such cases, a
question arises concerning the fate of the unassembled pro-
teins.
Several mammalian mitochondrial ATP-dependent pro-
teases have been described. The ATP-dependent Lon protease,
PIM1, was puri¢ed from the matrix fraction [6,7], and the
gene for the human homologue has been cloned [8]. Recently,
the inner membrane ATP-dependent, M-aaa, protease [9] and
the mitochondrial intermembrane space ATP-dependent pro-
tease, MISP1 [10], were also characterized and puri¢ed.
Although the physiological functions of these mammalian
proteases are not well understood, bacterial and yeast mito-
chondrial ATP-dependent proteases appear to mediate not
only proteolysis, but also the insertion of proteins into mem-
branes and the disassembly or oligomerization of protein
complexes (reviewed in [11,12]). Thus, the ATP-dependent
proteases may have a role in ensuring protein integrity and
the overall level of organellar biogenesis.
In view of the suggested, but poorly studied, role of protein
degradation in regulation of mitochondrial biogenesis in
mammals, we investigated the e¡ect of altered mitochondrial
biogenesis on the ATP-dependent proteolysis mediated by the
matrix Lon protease in isolated mitochondria. As model sys-
tems, we have used mitochondria from rapidly growing
Zajdela hepatoma cells and liver mitochondria from T3-
treated hypothyroid rats. The mitochondrial content of Zaj-
dela cells is severely reduced, possibly controlled by protease-
induced degradation [13], whereas thyroid hormone increases
the expression of the mitochondrial genome [14,15] and the
rate of mitochondrial protein degradation [16,17]. Here we
report that both the rapid growth of Zajdela cells and the
injection of hypothyroid rats with T3 are associated with in-
creased levels of the ATP-dependent Lon protease mRNA
and protein. Our ¢ndings are consistent with the participation
of the Lon protein in regulated organellar proteolysis.
2. Materials and methods
2.1. Animals, experimental tumor and hormone treatment
Male Wistar rats of 120^150 g were used for experiments with
Zajdela hepatoma. Zajdela hepatoma ascites cells was maintained
and propagated as described [18]. For hormone experiments male
Sprague-Dawley rats were used. Rats of 80 g were made hypothyroid
by providing Tapazol in their drinking water [5]. T3 (20 Wg/100 g body
mass) was injected daily for 3 days [5].
2.2. Isolation of mitochondria and mitochondrial matrix
Rat liver and hepatoma mitochondria were isolated as described
[18]. Treatment of the organelles with a low concentration of digito-
nin, which removed most of the contaminating microsomes, was per-
formed as detailed in [19]. Mitochondrial matrix was prepared by
sonicating mitochondria (20 mg/ml) on ice for 2 min at maximum
output followed by centrifugation for 30 min at 100 000Ug.
2.3. cDNA clones
cDNA clones for the Lon protease [8] and cytochrome c oxidase
subunit IV [20] were from human. cDNA for actin was from mouse.
2.4. RNA extraction and Northern analysis
Total RNA was extracted as described [21]. mRNA was prepared
by oligo(dT)-cellulose (Pharmacia Biotech) according to manufactur-
er’s instructions. The samples (5 Wg) were separated in 1.2% form-
aldehyde/agarose gels, transferred to nylon membranes (Hybond N,
Amersham) and hybridized with DNA probes according to standard
procedures. The mRNA was hybridized to 32P-labeled speci¢c cDNA
sequences which were labeled by random priming. Autoradiographs
were analyzed using an LKB 2222-020 Laser Ultrascan.
2.5. Miscellaneous methods
SDS-polyacrylamide gel electrophoresis [22], immunoblotting [23],
and hydrolysis of [14C]methylcasein to acid-soluble products [24] were
performed according to published procedures.
3. Results and discussion
ATP-dependent proteolytic activity was measured in iso-
lated rat liver and Zajdela hepatoma mitochondria in the
presence or absence of ATP (Table 1). Oligomycin and apyr-
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ase were used to inhibit the mitochondrial ATPase and to
hydrolyze the endogenous ATP and ADP, respectively [25].
The data, representing only the ATP-dependent activity, show
an approximately 6-fold higher ATP-dependent hydrolysis of
[14C]methylcasein in Zajdela hepatoma mitochondria com-
pared to normal rat liver. This value is even greater (8-fold)
when the data are corrected for ATP-independent hydrolysis.
Essentially the same results were obtained using the soluble
matrix fraction only (Table 1). These results suggest that,
under the experimental conditions used, the measured ATP-
dependent proteolytic activity may be attributed to the Lon
protease. To con¢rm this, we compared the levels of the ATP-
dependent protease in rat liver and Zajdela hepatoma mito-
chondria by Western blotting using antibodies against the rat
liver Lon protease (Fig. 1). In good agreement with activity
measurements, the levels of the ATP-dependent protease were
approximately 8-fold higher in Zajdela hepatoma mitochon-
dria than in rat liver mitochondria.
Steady-state levels of mRNA encoding the Lon protease
were also assayed. Fig. 2 shows a Northern blot analysis of
rat liver and Zajdela hepatoma mitochondria probed with
human Lon cDNA. Lon protease mRNA abundance in Zaj-
dela hepatoma was increased 18-fold over that in normal rat
liver (Fig. 3). COX IV mRNA on the other hand was only
2.5-fold more abundant in Zajdela hepatoma cells than in rat
liver, in agreement with previous results [13]. Therefore, the
content of the Lon mRNA in the tumor cells is approximately
4^6-fold higher than in their normal counterparts. These re-
sults extend our earlier observation of increased intramito-
chondrial proteolysis in tumor mitochondria [13] and suggest
this to be due to the enhanced expression of the Lon protease.
To test whether the observed induction of the Lon protease
in Zajdela hepatoma mitochondria is seen only in tumor cells
or is a more general reaction to changes in the state of mito-
chondrial biogenesis, experiments were performed with rat
liver mitochondria from hypothyroid and T3-treated hypothy-
roid animals. Thyroid hormone increases mitochondrial mass
[14,15] as well as the expression of mitochondrial genes [19]
and some nuclear-encoded genes of the oxidative phosphoryl-
ation system [26]. Hyperthyroidism was induced in hypothy-
roid rats by daily injections of 20 Wg T3/100 g body mass for
3 days. Lon protease activity in whole mitochondria and mi-
tochondrial matrix fractions from hypothyroid and T3-treated
hypothyroid animals are summarized in Table 2. An approx-
imately 2-fold increase in the ATP-dependent hydrolysis of
[14C]methylcasein is observed in whole mitochondria and ma-
trix fractions from T3-treated rats (Table 2). This correlates
well with the 2-fold increase in Lon protein observed in these
samples by Western blot analysis (Fig. 3) and a 3^4-fold in-
crease in Lon mRNA (Fig. 4) in T3-treated rat livers. Thus
the transition from the hypo- to the hyperthyroid state, which
results in approximately a doubling of mitochondrial mass
[14,15], is also associated with a similar increase in Lon pro-
tein and Lon activity.
In summary, our data show that increasing the rates of
biogenesis of mammalian mitochondria either by neoplastic
transformation (rapid cell growth and division) or by thyroid
hormone is associated with enhanced expression of the mito-
chondrial Lon protease. The physiological role of the in-
creased Lon protease in mitochondrial biogenesis remains to
be ¢rmly established. However, it is likely that both the rapid
growth and division of the Zajdela cell and T3 treatment of
rats induce a disproportionate expression of some OXPHOS
proteins, resulting in accumulation of unassembled subunits.
Unassembled, overexpressed subunits of mitochondrial pro-
teins in yeast are subject to degradation by the Lon protease
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Table 1
ATP-dependent degradation of [14C]methylcasein by mitochondrial
and matrix fractions of rat liver and Zajdela hepatoma
Fraction [14C]Methylcasein hydrolyzed/mg/h
liver hepatoma fold increase hepatoma/liver
Mitochondria 0.50 3.14 6.3
Matrix 0.81 4.60 5.7
Mitochondria* 0.30 2.64 8.5
Matrix* 0.59 3.98 6.8
Experimental details are given in Section 2. Values represent results
from three independent experiments and the standard error did not
exceed 10%. Values marked with asterisks were corrected for ATP-
independent activity (dependent3independent).
Fig. 1. The content of Lon protease in rat liver and Zajdela hepato-
ma mitochondria. Western blot analysis of the Lon protease was
performed as speci¢ed in Section 2. Isolated mitochondria were ¢rst
precipitated with 7% trichloroacetic acid, washed with cold water,
sonicated for 2 min in suspension and solubilized with SDS. The
amounts for both types of mitochondria were 12.5, 25 and 50 Wg,
respectively. RLM, rat liver mitochondria; ZHM, Zajdela hepatoma
mitochondria.
Fig. 2. Increased steady-state levels of the Lon protease in Zajdela
hepatoma. mRNA from rat liver and Zajdela hepatoma (5 Wg/lane)
was electrophoresed, transferred to nylon membrane and assayed as
described in Section 2. Lon, Lon protease; COX IV, cytochrome
oxidase subunit IV; RL, rat liver; ZH, Zajdela hepatoma.
Fig. 3. The content of Lon protease in hypothyroid and T3-treated
hypothyroid rats. Mitochondria were prepared from the livers of
three hypothyroid rats and three hypothyroid rats treated with 20
Wg T3/100 g body mass for 3 days. Western blot analysis and treat-
ment of mitochondria prior to electrophoresis were done as in Fig.
1. Each lane represents 50 Wg of mitochondria isolated from an in-
dividual animal. Lon, Lon protease.
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(see [12] and references therein). This scenario ¢ts with the
enhanced expression of the mitochondrial genome observed
in rapidly growing neoplastic cells [13] and in T3-treated ani-
mals [19,26], and with the increased turnover of mitochondrial
proteins in rapidly growing cells [13] and in rat liver after
thyroid hormone injection [16,17]. Moreover, it has recently
been demonstrated that the Lon protease is directly required
for expression of certain mitochondrially encoded proteins in
yeast [27].
However, the Lon protease is not the only protease in-
volved in controlling the proper assembly of multimeric com-
plexes. In yeast, the M-aaa complex is responsible for rapid
degradation of unassembled cytochrome oxidase subunit 2
[28] and subunits of the mitochondrial ATP synthase [29^
31]. Although we know little about the role of the M-aaa
complex in mammalian mitochondria, the present data dem-
onstrating nearly proportional increases in Lon protein and
ATP-dependent protease activity in two di¡erent experimental
systems suggest that the ATP-dependent Lon protease may
have the major role in the regulation of mitochondrial bio-
genesis in mammalian cells. This notion is compatible with the
growing body of evidence that ATP-dependent mitochondrial
proteases play an indispensable role in the overall regulation
of mitochondrial biogenesis.
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ATP-dependent degradation of [14C]methylcasein by mitochondrial
and matrix fractions of hypothyroid and T3-treated hypothyroid
rats
Fraction [14C]Methylcasein hydrolyzed/mg/h
hypo +T3 fold increase T3/hypo
Mitochondria* 0.154 0.365 2.4
Matrix* 0.263 0.583 2.2
Experimental details are given in Section 2. Values represent the mean
of three independent experiments and were corrected for ATP-inde-
pendent activity (dependent3independent). The standard error did
not exceed 10%.
Fig. 4. Thyroid hormone increases the steady-state levels of the Lon
transcript. mRNA was prepared from livers of three hypothyroid
and three T3-treated hypothyroid rats. Details of the T3 treatment
are given in Section 2. Each lane reperesents 5 Wg of mRNA from
an individual animal. Lon, Lon protease.
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